Catalyst
Slingshot members are tracking this event:
Roche’s Gazyvaro approved in Europe in combination with bendamustine for people with previously treated follicular lymphoma
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| RHHBY |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 16, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Gazyvaro, Obinutuzumab, Phase Iii Gadolin Study, Bendamustine
